CRMD
CorMedix Inc
NASDAQ: CRMD · HEALTHCARE · BIOTECHNOLOGY
$7.19
-2.18% today
Updated 2026-07-29
Market cap
$631.54M
P/E ratio
3.66
P/S ratio
1.58x
EPS (TTM)
$2.20
Dividend yield
—
52W range
$6 – $15
Volume
1.3M
CorMedix Inc (CRMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.19
12-Month target
$5.29
2030 Target
$13.86
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 3.66x (capped 25x) · Margin: 45.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.